Skip to main content
OpenTrials
Completed

NCT Number: NCT06553170

Anesthetic Management of Diabetes in Perioperative Urology and Visceral Surgery

It is recognized that a poor glycemic, pre- and intraoperative balance is the source of increase in morbimortality. There was no local protocol at the CHRU Brest regarding the perioperative management of the diabetic patient. This retrospective observational work aims to assess the application of the French recommendations for the perioperative management of diabetes, and compare management before and after the introduction of a protocol based on its recommendations published in 2017 by the SFAR.

The main endpoint is the percentage of patients for whom half of the patients recommendations from the local protocol were implemented for each of the recommendations evaluated and applicable to each patient, before and after protocol and staff training.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Cadic

Brest, Brittany Region, 29200, France

About this study

Half of the recommandations are implemented for each recommendation evaluated applicable in 29% of patients(n=25) in the before group versus 66.23% (n=52) in the after group (p<0.05).

This corresponds to an improvement significant of 36.23% for our primary endpoint.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients diabetics
  • urology or visceral surgery

Exclusion criteria

  • ambulatory surgery

Treatment and study plan

Primary outcomes

  1. follow the recommendations

    Time frame: 1 year after

    The main endpoint is the percentage of patients for whom half of patients recommendations of the local protocol were implemented for each of the recommendations evaluated and applicable to each patient, before and after the application of the protocol and training staff.

Secondary outcomes

  1. complications and mortality

    Time frame: 1 year after

    Secondary endpoints are hospital mortality, the occurrence of early postoperative complications related to diabetes, the occurrence of complications post-operative surgery, and finally the occurrence of medical complications not related to Diabetes.

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Anesthetic Management of Diabetes in Perioperative Urology and Visceral Surgery: Adherence to a New Protocol at Brest CHU

Acronym: DIAPRO-BREST

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Aug 14, 2024
Registry last updated
Aug 14, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.